PLK1 and non-small cell lung carcinoma: Overexpression of polo-like kinase 1 (PLK1) is a negative prognostic factor for NSCLC patients and patients suffering from some other solid tumors, like esophageal carcinoma, head and neck tumors and melanoma [18].